Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis

Folia Histochemica et Cytobiologica

Volumn 47, Issue 2, 2009, Pages 225-230

  Kucejko, Wojciech ^a   Chyczewska, Elzbieta ^a   Naumnik, Wojciech ^a   Ossolińska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Allergic extrinsic alveolitis; Clara cell protein; IL 10; Interstitial lung disease; Pulmonary fibrosis; Sarcoidosis; Surfactant protein D

Indexed keywords

BIOCHEMICAL MARKER; CLARA CELL PROTEIN; INTERLEUKIN 10; SURFACTANT PROTEIN D;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; CHRONIC RESPIRATORY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INFLAMMATION; LUNG ALVEOLITIS; LUNG FIBROSIS; LUNG GRANULOMA; LUNG LAVAGE; LUNG PARENCHYMA; LUNG SARCOIDOSIS; MALE; STATISTICAL SIGNIFICANCE;

EID: 73549096677     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0028-9     Document Type: Article

References (28)

1. Honda Y et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 1995;152:1860-1866.
2. Janssen R et al. Study of Clara cell 16, KL-6, and surfactant protein D in serum as disease markers in pulmonary sarcoidosis. Chest. 2003;124:2119-2125.
3. Ohnishi H et al. Comparative study of KL-6, surfactant protein A, surfactant protein D, and monocyte chemoattractant protein 1 as serum markers for interstitial lung disease. Am J Respir Crit Care Med. 2002;165:378-381.
4. Miele L. et al. Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor. Endocr Rev. 1987;8:474-490.
5. Bernard A et al.: Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J. 1992;5:1231-1238.
6. Hermans C. et al. Lung epithelium specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med. 1999;159:646-678.
7. American Thoracic Society/European Respiratory Society. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160:736-755.
8. Patel AM et al. Hypersensivity pneumonitis: Current concepts and future questions. J Allergy Clin Immunol. 2001;108(5):661-670.
9. Klech H et al. Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumonology Task Group on BAL. Eur Respir J. 1990;3:937-974.
10. Klech H et al. Technical recommendations and guidelines for BAL. Report of the European Society of Pneumonology Task Group on BAL. Eur Respir J. 1989;2:561-585.
11. Ryu JH, Daniels CE, Hartman TE et al. Diagnosis of interstitial lung diseases. Mayo Clin Proc. 2007;82(8):976-86.
12. Tötsch M, Guzman J, Theegarten D, et al.: Bronchoalveolar lavage. Pathologie. 2007;29.
13. Honda Y et al. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest. 1996;109:1006-1009.
14. Bernard A et al. The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids. Clin Chim Acta. 1993;223:189-191.
15. Ishii S et al. Protein 1: its purification and application in clinical medicine. J Clin. Lab. Anal. 1993;7:394-400.
16. Shijudo N et al. Serum and BAL Clara cell protein levels, and CC-10-positive bronchiolar cells are decreased in smokers. Eur Respir J. 1997;10:1108-1114.
17. Hermans C. et al. Serum Clara cell protein (CC-16) correlates with chest radiographic abnormalities of sarcoidosis. Am J Respir Crit Care Med. 1997;155:981.
18. Ishii H et al. High serum concentration of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax. 2003;58:52-57.
19. Greene KE et al. Serum surfactant protein A and D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002;19:439-446.
20. Lumsden AB et al. Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers. Thorax. 1984;39:844-849.
21. Nomori H et al. Clinicopathological examination of the relation between Clara cells and smoking. Kyobu Geka. 1994;47:888-891.
22. Jorens PG et al. Potential role of of Clara cell protein, an endogenous phpspholipase-A2 inhibitor, in acute lung injury. Eur Respir J. 1995;8:1647-1653.
23. Lesur O et al. Clara cell protein (CC-16) and surfactant- associated protein A (SP-A) in asbestos-exposed workers. Chest. 1996;109:467-474.
24. Lesur O et al. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med. 1995;152:290-297.
25. Kunitake R et al. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respiration. 2001;68:488-495.
26. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am. J. Respir. Crit Care Med. 2002;165:277-304.
27. American Thoracic Society/European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am. J. Respir. Crit. Care Med. 2000;161:646-664.
28. Wesołowski S: Idiopatyczne śródmia̧szowe zapalenia płuc. In: Rowińska-Zakrzewska E, ed. Choroby układu oddechowego. PZWL, Warszawa; 2004:221-237.129.